Update on the efficacy, effectiveness and safety of artemether–lumefantrine combination therapy for treatment of uncomplicated malaria

Simple item page
dc.creatorByakika-Kibwika, Pauline
dc.creatorLamorde, Mohammed
dc.creatorMayanja-Kizza, Harriet
dc.creatorMerry, Concepta
dc.creatorColebunders, Bob
dc.creatorvan Geertruyden, Jean-Pierre
dc.date2012-01-18T13:08:48Z
dc.date2012-01-18T13:08:48Z
dc.date2009-12-16
dc.date.accessioned2018-09-04T12:32:22Z
dc.date.available2018-09-04T12:32:22Z
dc.descriptionArtemether–lumefantrine is one of the artemisisnin-based combination therapies recommended for treatment of uncomplicated falciparum malaria. The drug combination is highly efficacious against sensitive and multidrug resistant falciparum malaria. It offers the advantage of rapid clearance of parasites by artemether and the slower elimination of residual parasites by lumefantrine. The combination can be used in all populations except pregnant mothers in the first trimester where safety is still uncertain. There are still concerns about safety and pharmacokinetics of the drug combination in children, especially infants, pregnant mothers and drug interactions with mainly non-nucleoside reverse transcriptase inhibitors and protease inhibitors used for HIV therapy.
dc.identifierByakika-Kibwika, P., Lamorde, M., Mayanja-Kizza, H., Merry, C., Colebunders, B., van Geertruyden, J.P. (2009). Update on the efficacy, effectiveness and safety of artemether–lumefantrine combination therapy for treatment of uncomplicated malaria. Therapeutics and Clinical Risk Management, 6
dc.identifier1176-6336
dc.identifierhttp://hdl.handle.net/10570/335
dc.identifier.urihttp://hdl.handle.net/10570/335
dc.languageen
dc.publisherDove Medical Press
dc.subjectArtemether–lumefantrine
dc.titleUpdate on the efficacy, effectiveness and safety of artemether–lumefantrine combination therapy for treatment of uncomplicated malaria
dc.typeJournal article, peer reviewed
dc.typeLearning Object
Files
Collections
Dissertation and Thesis